You are here

Amgen

Amgen speaks out about bone density concerns with obesity drug

Clinical Trials Arena

Thu, 11/14/24 - 10:06 am

BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink

Fierce Pharma

Wed, 11/13/24 - 09:49 pm

Bristol Myers Squibb

Hidden data on obesity prospect wipe $12B off Amgen market cap

Fierce Biotech

Wed, 11/13/24 - 11:10 am

clinical trials

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial

Clinical Trials Arena

Fri, 11/8/24 - 11:34 am

clinical trials

chronic rhinosinusitis with nasal polyps

Amgen reaps Horizon buyout rewards in Q3 as it gears up for key biosim launches

Fierce Pharma

Thu, 10/31/24 - 09:43 am

Amgen Whets Investors’ Appetites for MariTide Obesity Data by End of Year

BioSpace

Thu, 10/31/24 - 09:42 am

Regeneron loses bid to block Amgen's Eylea biosimilar launch in US

Reuters

Tue, 10/22/24 - 11:30 pm

FDA Pushes Back PDUFA Dates for Amgen and Intercept

BioSpace

Fri, 10/18/24 - 11:28 am

colorectal cancer

Intercept Pharma

primary biliary cholangitis

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

BioPharma Dive

Fri, 10/11/24 - 11:10 am

Skye Bioscience

Amgen must face lawsuit claiming it hid $10.7 billion tax bill

Reuters

Tue, 10/1/24 - 10:22 pm

Amgen, Family Heart Foundation launch at-home cholesterol screening for LDL-C Awareness Day

Medical Marketing and Media

Mon, 09/30/24 - 08:47 pm

Cholesterol Connect

Amgen claims success for two immune drugs, but results underwhelm Wall Street

BioPharma Dive

Wed, 09/25/24 - 11:46 am

atopic dermatitis

myasthenia gravis

Amgen's muscular disorder drug meets main goal in late-stage study

Reuters

Tue, 09/24/24 - 09:59 pm

clinical trials

myasthenia gravis

Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar

Fierce Pharma

Tue, 09/24/24 - 11:56 am

Where Will Amgen Be in 5 Years?

Motley Fool

Fri, 09/20/24 - 10:14 am

Weight-loss market to see 16 new drugs by 2029, report estimates

Reuters

Tue, 09/10/24 - 04:29 pm

Boehinger Ingelheim

Structure Therapeutics

Viking Therapeutics

Viridian says thyroid eye disease drug effective in reducing symptoms

Reuters

Tue, 09/10/24 - 09:47 am

Viridian Therapeutics

thyroid eye disease

clinical trials

Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases

BioSpace

Thu, 09/5/24 - 11:40 am

Roche tops pharma rivals for reputation among rare disease patient groups

Medical Marketing and Media

Wed, 08/21/24 - 11:39 am

BioMarin creates new-look R&D and deal teams with Roche’s Sabry, Amgen’s Friberg

Fierce Biotech

Wed, 08/21/24 - 11:31 am

Pages